05/08/2024
8:13 AM | Janux Therapeutics (Filer)
| Form S-3ASR | |
05/07/2024
7:05 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:14 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
3:16 PM | Janux Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
3:20 PM | Janux Therapeutics (Filer)
| Form DEFA14A | |
03/08/2024
3:47 PM | Janux Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/08/2024
3:23 PM | Janux Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/06/2024
5:54 PM | Janux Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
03/06/2024
3:15 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:07 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
03/04/2024
6:31 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:44 PM | Gujrathi Sheila (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:33 PM | CAPPS VICKIE L (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:30 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
02/29/2024
4:11 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
8:55 PM | Janux Therapeutics (Subject)
| Form FWP | |
02/28/2024
4:15 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
8:50 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
02/27/2024
4:23 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:43 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Janux Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
3:31 PM | Campbell David Alan (Filed by)
Janux Therapeutics (Subject)
| Form SC 13G/A | |
01/03/2024
3:49 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:50 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:52 PM | Janux Therapeutics (Issuer)
Reardon Tighe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:53 PM | Janux Therapeutics (Issuer)
Robinson Byron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:54 PM | Janux Therapeutics (Issuer)
Winter Charles M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:46 PM | Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:48 PM | Janux Therapeutics (Issuer)
Reardon Tighe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
6:11 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
3:19 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/07/2023
5:14 PM | Godfrey Wayne (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
3:33 PM | Godfrey Wayne (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/21/2023
3:31 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
4:24 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
07/18/2023
3:16 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
7:06 AM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
7:16 AM | Janux Therapeutics (Subject)
| Form FWP | |
07/10/2023
3:01 PM | CITADEL ADVISORS LLC (Filed by)
Janux Therapeutics (Subject)
| Form SC 13G | |
06/23/2023
3:36 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
4:17 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:06 PM | Barrett Ronald W (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
What President Biden's new law means for investors (Ad) What's Got Musk, Bezos, and Gates So Excited?
Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it. This expert just went public with all the details, including which stocks to jump on immediately. |
06/16/2023
4:06 PM | CAPPS VICKIE L (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:07 PM | Gujrathi Sheila (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:08 PM | Janux Therapeutics (Issuer)
Kung Winston (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:08 PM | Janux Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:09 PM | Janux Therapeutics (Issuer)
McNulty Alana B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:10 PM | Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
4:15 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2023
3:45 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Janux Therapeutics (Subject)
| Form SC 13G | |
